Growth Metrics

Intelligent Bio Solutions (INBS) Free Cash Flow Growth (3y) (2023 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 -111.63%
Dec 31, 2024 -17.71%
Sep 30, 2024 -213.38%
Mar 31, 2024 26.52%
Dec 31, 2023 -54.57%
Sep 30, 2023 21.16%
Jun 30, 2023 -70.96%
Mar 31, 2023 -125.84%